Biogen ‘turning the corner’ as Leqembi and Skyclarys launches advance, but much work remains to be done: CEO fkansteiner Wed, 04/24/2024 – 11:26 More: Biogen 'turning the corner' as Leqembi and Skyclarys launches advance, but much work remains to be
read moreRoche’s Vabysmo shows no sign of slowdown after Regeneron and Bayer’s launch of Eylea HD kdunleavy Wed, 04/24/2024 – 10:58 More: Roche's Vabysmo shows no sign of slowdown after Regeneron and Bayer's launch of Eylea HD Source: fierce
read moreChiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents ntaylor Wed, 04/24/2024 – 09:48 More: Chiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents Source: fierce
read moreThe progressive neurodegenerative condition is the most common form of dementia More: UCL study to assess link between navigation and AD using virtual reality Source: News
read moreAccording to the World Health Organization, CVDs are responsible for an estimated 17.9 million deaths every year More: New heart disease calculator more accurately predicts patients’ risk of CVDs Source: News
read moreAbbVie starts open casting call for next faces of Botox ads, doubling down on pitch to everyday users ntaylor Wed, 04/24/2024 – 06:04 More: AbbVie starts open casting call for next faces of Botox ads, doubling down on pitch to
read more© 1994 - 2026 B.M. Pharmaceuticals